Skip to main content
The Role, Rationale, Evidence and Practical Application of
Combination Therapy with DTE in Selected Patients with Hypothyroidism
A Year 2021 Hypothyroidism Update for the Endocrinology, Primary Care, Internal Medicine, and Thyroid Specialist
Interpreting Sensor-Based Glucose Metrics, Time in Range and Ambulatory Glucose Profiles (AGP)
Optimizing eA1c and the Glucose Management Indicator (GMI) in Persons with Diabetes Requiring and Not Requiring Insulin Therapy
A Three-Module Virtual Symposium
Evidence, Guidelines, Mechanisms, and Trials Supporting Biologics-Based
Targeting of Type 2 Cytokine Signaling Proteins for Moderate-to-Severe AD in
Children, Adolescents and Adults
A Year 2020 Clinical Practice Roadmap for the Pediatric and Adult Dermatology Specialist, Clinical Immunologist, Adolescent Physician, Allergist, Pediatrician and Related Specialists LEARN MORE >
Importance of Early Diagnosis, Testing, and Recognition of Unusual and Heterogeneous Symptoms and Hallmarks of

Fabry Disease Across Multiple Clinical Specialties
A Year 2020 Diagnostic, Assessment, and Fabry Disease Management Update for the GI, Neurological, Renal, CV, Dermatologic and Clinical Genetics Specialist LEARN MORE >
Therapeutic Advances, Novel Formulations and Patient Adherence for Optimizing Management of
Focus on the Safety, Evidence and Rationale for Inhaled Antimicrobial Suspension
ECP in CTCL, GVHD, Solid Organ Transplant Rejection, and Scleroderma Focus on the Evidence and Clinical Applications at the Front Lines of Patient Care LEARN MORE >
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction Focus on Trial-Based Evidence for PCSK9-Mediated LDL-C Lowering to Optimize Treatment and Prevention of ASCVD LEARN MORE >
Optimizing Glycemic Regulation Through Combination Therapy Focus on the Safety, Convenience,  HA1c Control, Reducing Risk of Hypoglycemia, and Efficacy of Combination Basal Insulin-GLP-1 RA Regimens in T2D LEARN MORE >

Featured Specialties